Ron Cohen, President and CEO, Acorda Therapeutics, Inc.
Ron Cohen, President and CEO, Acorda Therapeutics, Inc.
Type:
Video
Dr. Cohen discusses the plight of today’s emerging biotech companies, and how the federal government can best support innovation within the industry so that the U.S. remains globally competitive. Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with MS, spinal cord injury and other neurological conditions.
June 29, 2011
|
June 28, 2011
|
June 27, 2011
|
June 27, 2011
|
June 22, 2011
|
June 21, 2011
|
June 20, 2011
|
June 17, 2011
|
